Case-based educational intervention to assess change in providers' knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline

Atherosclerosis
Yashashwi PokharelSalim S Virani

Abstract

Prior studies have shown provider-level knowledge gaps regarding the 2013 American College of Cardiology/American Heart Association guideline on the treatment of cholesterol and concerns about 10-year atherosclerotic cardiovascular disease (ASCVD) risk estimation. The effect of an educational intervention to mitigate knowledge gaps is unknown. We developed a questionnaire and administered it to providers before (pre-training) and after (post-training) a case-based educational intervention across 6 sites in Texas. The intervention highlighted the key recommendations of the 2013 guideline and the differences from the prior guideline mainly using clinical-vignettes. Several practice pertinent items were also discussed. Most participants were providers-in-training (78%) in internal medicine (68%). Compared to pre-training, the post-training metrics were: 43% vs. 82% for providers' ability to identify 4 statin benefit groups; 47% vs. 97% for their awareness of the ASCVD risk threshold of ≥ 7.5% to initiate discussion about risks/benefits of statin therapy; 9% vs. 40% for awareness of differences between the Framingham and the ASCVD risk estimator; 26% vs. 78% for awareness of the definition of statin intensity; 35% vs. 62% for using...Continue Reading

References

Oct 27, 1999·JAMA : the Journal of the American Medical Association·M D CabanaH R Rubin
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Aug 23, 2005·International Journal of Technology Assessment in Health Care·Bernard S Bloom
Aug 23, 2011·The American Journal of Medicine·Salim S ViraniChristie M Ballantyne
Jan 24, 2012·Journal of Clinical Lipidology·Smita I NegiSalim S Virani
Sep 8, 2012·Australian Journal of Primary Health·Kirsten KirschnerRichard Grol
Nov 26, 2013·Lancet·Paul M Ridker, Nancy R Cook
Mar 22, 2014·The New England Journal of Medicine·Michael J PencinaEric D Peterson
Dec 3, 2014·The American Journal of Cardiology·Salim S ViraniLaura A Petersen
Apr 4, 2015·The American Journal of Medicine·Sina JaméKirsten E Fleischmann

❮ Previous
Next ❯

Citations

Jan 17, 2020·Expert Review of Cardiovascular Therapy·Dhruv MahttaSalim S Virani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

© 2022 Meta ULC. All rights reserved